Family · Pharmaceutical analytical standards
Nalfurafine
A selective kappa opioid receptor agonist that relieves itching, approved in Japan in 2009 for uraemic pruritus in people with chronic kidney disease on haemodialysis. This family brings together the active ingredient and other impurities.
Did you know?It was the first selective kappa agonist approved for clinical use; obtained by modifying the structure of naltrexone, it started out as a potential painkiller.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
